Colby Cosh: Did Ozempic kill its Canadian patent?

“Ladies and gentlemen, the moment has arrived: generic versions of the miracle weight-loss drug semaglutide , best known under its corporate trade names of Ozempic and Wegovy, are now beginning to arrive on Canadian pharmacy shelves. This will, perhaps, provide fresh data on one of the great unresolved questions of our time: was Novo Nordisk’s unnecessary loss of its exclusive Canadian rights to the drug a mistake, or an intentional strategy? Read More

Summary generated from the RSS feed of National Post. All article rights belong to the original publisher. Click through to read the full piece on nationalpost.com.